Evidence map›Paper›PMID 36608021›Full record

ArticlePloS one2023

Design and quantitative evaluation of 'Aerosol Bio-Containment Device (ABCD)' for reducing aerosol exposure during infectious aerosol-generating events.

Michael S Waring, L James Lo, Michael A Kohanski, Elizabeth Kahle, Ian M Marcus, Heather Smith, Kara L Spiller, Sharon L Walker

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael S WaringDepartment of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, United States of America.ORCID 0000-0002-1864-9268
L James LoDepartment of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, United States of America.
Michael A KohanskiDivision of Rhinology, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Elizabeth KahleSchool of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, United States of America.ORCID 0000-0001-8394-459X
Ian M MarcusDepartment of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, United States of America.
Heather SmithLife Sciences Department, Riverside City College, Riverside, CA, United States of America.ORCID 0000-0001-8691-2032
Kara L SpillerSchool of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, United States of America.
Sharon L WalkerDepartment of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic renewed interest in infectious aerosols and reducing risk of airborne respiratory pathogen transmission, prompting development of devices to protect healthcare workers during airway procedures. However, there are no standard methods for assessing the efficacy of particle containment with these protective devices. We designed and built an aerosol bio-containment device (ABCD) to contain and remove aerosol via an external suction system and tested the aerosol containment of the device in an environmental chamber using a novel, quantitative assessment method. The ABCD exhibited a strong ability to control aerosol exposure in experimental and computational fluid dynamic (CFD) simulated scenarios with appropriate suction use and maintenance of device seals. Using a log-risk-reduction framework, we assessed device containment efficacy and showed that, when combined with other protective equipment, the ABCD can significantly reduce airborne clinical exposure. We propose this type of quantitative analysis serves as a basis for rating efficacy of aerosol protective enclosures.

Indexed as

COVID-19HumansInfectious Disease Transmission, Patient-to-ProfessionalPersonal Protective EquipmentProtective DevicesRespiratory Aerosols and Droplets

Identifiers

PMID36608021
PMCPMC9821519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.